Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-30

Clinical Trial Update: The Efficacy and Safety of 3% Povidone-Iodine in Acne Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assesses the efficacy and safety of a 3% povidone-iodine solution for acne therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 3% Povidone-Iodine (povidone-iodine (3% solution))

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Acne | Phase 2 | Status: UNKNOWN